Rawalpindi: Ferozsons Laboratories Limited has scheduled an Extraordinary General Meeting (EOGM) for its shareholders on Friday, July 3, 2026, at Hotel Blue Lagoon, Masood Akhter Kiani Road, Rawalpindi. The meeting will also be accessible through a video link to ensure broader participation.

The agenda for the EOGM includes the confirmation of minutes from the 69th Annual General Meeting held on October 25, 2025, and the election of seven directors for a three-year term beginning July 7, 2026. This election follows the recent passing of Mrs. Akhter Khalid Waheed, Chairperson of the Board, on June 1, 2026. The six remaining retiring directors eligible for re-election are Mr. Osman Khalid Waheed, Mrs. Amna Piracha Khan, Mrs. Munize Azhar Peracha, Mr. Shahid Anwar, Mr. Arshad Saeed Husain, and Mr. Suleman Ghani.

In preparation for the EOGM, the company's Share Transfer Books will be closed from June 27, 2026, to July 3, 2026, with all transfers needing to be finalized by June 26, 2026, to be eligible for meeting attendance and voting. Shareholders interested in contesting for a director position are required to submit their candidacy documents no later than 14 days before the EOGM.

The company has made provisions for shareholders to attend the meeting electronically, requiring registration with the necessary identification documents 48 hours before the EOGM. The election process for directors will comply with the Companies Act, 2017, and other relevant regulations, including the possible use of postal ballots and electronic voting if the number of candidates exceeds the positions available.

Additionally, Ferozsons Laboratories Limited has reiterated the prohibition on gift distribution during the meeting, in accordance with directives from the Securities and Exchange Commission of Pakistan (SECP).

The company is listed under the designated market category of Pharmaceuticals on the Pakistan Stock Exchange. According to information available from the Pakistan Stock Exchange (PSX), Ferozsons Laboratories Limited continues to adhere to regulatory requirements and corporate governance standards.

Shareholders are encouraged to update their personal details with the company's share registrar or through their respective CDC accounts to ensure seamless participation in the EOGM.